Immediate Impact
61 standout
Citing Papers
Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis
2023 Standout
Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis
2023 Standout
Works of Eric S. Schned being referenced
Etanercept in combination with sulfasalazine, hydroxychloroquine, or gold in the treatment of rheumatoid arthritis.
2006
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Eric S. Schned | 9 | 11 | 48 | 48 | 28 | 11 | 136 | |
| Miriam García‐Arias | 23 | 78 | 105 | 30 | 8 | 218 | ||
| Shweta Bhagat | 12 | 54 | 57 | 13 | 10 | 106 | ||
| James McIntosh | 13 | 21 | 25 | 15 | 9 | 121 | ||
| Darren Tabechian | 2 | 23 | 48 | 7 | 18 | 8 | 131 | |
| Erik Waaler | 4 | 17 | 41 | 17 | 12 | 17 | 139 | |
| Adam Rischin | 6 | 36 | 91 | 6 | 10 | 140 | ||
| Yanqing Dong | 10 | 4 | 58 | 28 | 9 | 9 | 145 | |
| Éric Veillard | 2 | 16 | 29 | 52 | 14 | 13 | 127 | |
| Baptiste Glace | 1 | 6 | 86 | 49 | 32 | 9 | 160 | |
| Vander Fernandes | 6 | 22 | 103 | 36 | 30 | 13 | 199 |
All Works
Loading papers...